Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis

Jennifer H Ku, Lei Qian, Lina S Sy, Bradley K Ackerson, Emily Rayens, Yi Luo, Sijia Qiu, Lanfang Xu, Gina S Lee, Punam P Modha, Cheyne F Hoke, Cynthia Joe, Britta I Amundsen, Jean-Yves Pirçon, Lauriane Harrington, Nicolas Lecrenier, David Singer, Elizabeth M La, Andrew G Allmon, Dominique Luyts, Hung-Fu Tseng

Open source

DOI
10.1093/ofid/ofag279
Published
2026-04-28
Container
Open Forum Infectious Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag279,
  title = {Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis},
  author = {Jennifer H Ku and Lei Qian and Lina S Sy and Bradley K Ackerson and Emily Rayens and Yi Luo and Sijia Qiu and Lanfang Xu and Gina S Lee and Punam P Modha and Cheyne F Hoke and Cynthia Joe and Britta I Amundsen and Jean-Yves Pirçon and Lauriane Harrington and Nicolas Lecrenier and David Singer and Elizabeth M La and Andrew G Allmon and Dominique Luyts and Hung-Fu Tseng},
  year = {2026},
  journal = {Open Forum Infectious Diseases},
  doi = {10.1093/ofid/ofag279},
  url = {https://doi.org/10.1093/ofid/ofag279}
}

RIS

TY  - JOUR
TI  - Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis
AU  - Jennifer H Ku
AU  - Lei Qian
AU  - Lina S Sy
AU  - Bradley K Ackerson
AU  - Emily Rayens
AU  - Yi Luo
AU  - Sijia Qiu
AU  - Lanfang Xu
AU  - Gina S Lee
AU  - Punam P Modha
AU  - Cheyne F Hoke
AU  - Cynthia Joe
AU  - Britta I Amundsen
AU  - Jean-Yves Pirçon
AU  - Lauriane Harrington
AU  - Nicolas Lecrenier
AU  - David Singer
AU  - Elizabeth M La
AU  - Andrew G Allmon
AU  - Dominique Luyts
AU  - Hung-Fu Tseng
PY  - 2026
JO  - Open Forum Infectious Diseases
DO  - 10.1093/ofid/ofag279
UR  - https://doi.org/10.1093/ofid/ofag279
ER  - 

APA

Ku, J. H., Qian, L., Sy, L. S., Ackerson, B. K., Rayens, E., Luo, Y., Qiu, S., Xu, L., Lee, G. S., Modha, P. P., Hoke, C. F., Joe, C., Amundsen, B. I., Pirçon, J., Harrington, L., Lecrenier, N., Singer, D., La, E. M., Allmon, A. G., Luyts, D., & Tseng, H. (2026). Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag279

Source records